Tardive dyskinesia: are first signs reversible?
Abstract
Although tardive dyskinesia, a serious and sometimes irreversible side effect of antipsychotic drug use, is becoming increasingly common, there is still considerable confusion concerning the course of the syndrome. The authors observed 12 psychiatric patients with tardive dyskinesia from the inception of the syndrome. They found that first symptoms rarely persisted if antipsychotics were discontinued and concluded that the length of time symptoms have persisted prior to drug discontinuation, not age at onset, may be the major variable determining reversibility of the syndrome.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is likely considerable interindividual variability in the tapering process, with patients able to tolerate greatly varying rates of reduction; some long-term treated patients may need longer periods, and some first-episode patients or those treated for briefer periods may tolerate shorter tapering periods.
“There is likely to be considerable interindividual variability in this process, with patients able to tolerate greatly varying rates of reduction: given the data on time for TD to resolve, some long-term treated patients may need longer periods, and some first-episode patients or those treated for briefer periods may tolerate shorter tapering periods.75,76,78,101”
From A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (2021) · cites this paper as [101]
Cites
Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250081011 · Cited by 140 · see citing works
A Study of Facial Dyskinesia in a Mental Hospital Population
Brandon, S., McClelland, H. A., & Protheroe, C. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.118.543.171 · Cited by 138 · see citing works
Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250086012 · Cited by 109 · see citing works
Extrapyramidal Disorders After Prolonged Phenothiazine Therapy
Kennedy, P. F., Hershon, H. I., & McGuire, R. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.118.546.509 · Cited by 98 · see citing works
Choline for Tardive Dyskinesia
Davis, K. L., Berger, P. A., & Hollister, L. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507172930317 · Cited by 89 · see citing works
HL-A Antigens and Antibody Response after Influenza a Vaccination
Spencer, M. J., Cherry, J. D., & Terasaki, P. I. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601012940104 · Cited by 85 · see citing works
Neurological Syndromes Associated With Antipsychotic Drug Use
Freedman, D. X. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750340009001 · Cited by 84 · see citing works
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia
Klawans, H. L., & McKendall, R. R. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90087-6 · Cited by 71 · see citing works
Tardive Dyskinesia and Drug Therapy in Geriatric Patients
Crane, G. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760090055009 · Cited by 59 · see citing works
Axelrod, J. (1974) · Scientific American · doi:10.1038/scientificamerican0674-58 · Cited by 59 · see citing works
Deanol: A Solution for Tardive Dyskinesia?
MILLER, E. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410102911520 · Cited by 47 · see citing works
Tardive Dyskinesia: Its Relation to Neuroleptic and Antiparkinson Drugs
Turek, I., Kurland, A. A., Hanlon, T. E., & BOHM, M. (1972) · The British Journal of Psychiatry · doi:10.1192/bjp.121.6.605 · Cited by 33 · see citing works
Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750300086016 · Cited by 27 · see citing works
Simpson, G. M. (1973) · The British Journal of Psychiatry · doi:10.1192/bjp.122.5.618 · Cited by 27 · see citing works
Moline, R. A. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.5.534 · Cited by 22 · see citing works
Rapid Reversal of Tardive Dyskinesia
Crane, G. E. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.10.1159 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age
Smith, J. M. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780250054006 · Cited by 310 · see citing works
Dopaminergic supersensitivity after neuroleptics: time-course and specificity
Muller, P., & Seeman, P. (1978) · Psychopharmacology · doi:10.1007/bf00429171 · Cited by 271 · see citing works
“Early withdrawal after the dyskinetic symptoms are first observed improves the prognosis (Crane, 1973; Quitkin et al., 1977).”
BackgroundTardive Dyskinesia—Reversible and Persistent
Jeste, D. V. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050095012 · Cited by 199 · see citing works
Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia
Casey, D. E. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90029-q · Cited by 190 · see citing works
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.10.1163 · Cited by 190 · see citing works
Johnson, D. A. W., Pasterski, G., Ludlow, J. M., Street, K., & Taylor, R. D. W. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb00351.x · Cited by 160 · see citing works
“gested as causes, or Contributory causes, of T-D (23-34).”
BackgroundTherapeutic Strategies Against Tardive Dyskinesia
Jeste, D. V. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070037008 · Cited by 160 · see citing works
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157 · see citing works
Factors related to tardive dyskinesia
Chouinard, G., Annable, L., Ross‐Chouinard, A., & Nestoros, J. N. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.1.79 · Cited by 150 · see citing works
Miller, R. J., & Chouinard, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90044-e · Cited by 133 · see citing works
Penrsistent Tardive Dyskinesia in Bipolar Patients
Mukherjee, S. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040052008 · Cited by 112 · see citing works
Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication
Glazer, W. M., Morgenstern, H., Schooler, N., Berkman, C. S., & Moore, D. C. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.4.585 · Cited by 106 · see citing works
Neuroleptic-Induced Acute Extrapyramidal Syndromes and Tardive Dyskinesia
Casey, D. E. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30166-7 · Cited by 101 · see citing works
Antipsychotic-induced extrapyramidal symptoms and their management
Dayalu, P., & Chou, K. L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.9.1451 · Cited by 99 · see citing works
In Search of Treatment for Tardive Dyskinesia: Review of the Literature*
Jeste, D. V., & Wyatt, R. J. (1979) · Schizophrenia Bulletin · doi:10.1093/schbul/5.2.251 · Cited by 93 · see citing works
Neuroleptic Side Effects: Acute Extrapyramidal Syndromes and Tardive Dyskinesia
Casey, D. E., & Keepers, G. A. (1988) · Springer eBooks · doi:10.1007/978-3-642-73280-5_7 · Cited by 75 · see citing works
Adverse Effects of Antipsychotic Agents
Simpson, G. M., Pi, E. H., & Sramek, J. J. (1981) · Drugs · doi:10.2165/00003495-198121020-00004 · Cited by 73 · see citing works
The Medical Care of Patients With Psychiatric Illness
Karasu, T. B., Waltzman, S. A., Lindenmayer, J., & Buckley, P. J. (1980) · Psychiatric Services · doi:10.1176/ps.31.7.463 · Cited by 70 · see citing works
Zutshi, D., Factor, S., & Cloud, L. J. (2014) · PubMed Central · doi:10.7916/d85h7dzx · Cited by 67 · see citing works
Glazer, W. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790170097011 · Cited by 64 · see citing works
Overview: public health issues in tardive dyskinesia
Gárdos, G., & Cole, J. O. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.776 · Cited by 64 · see citing works
Soares‐Weiser, K., & Rathbone, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000459.pub2 · Cited by 60 · see citing works
Tardive dyskinesia and antiparkinsonian medication
Chouinard, G., de Montigny, C., & Annable, L. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.2.228 · Cited by 58 · see citing works
Hauser, R. A., Meyer, J. M., Factor, S. A., Comella, C., Tanner, C. M., Xavier, R. M., Caroff, S. N., & Lundt, L. (2020) · CNS Spectrums · doi:10.1017/s109285292000200x · Cited by 57 · see citing works
“DRBA treatment should be reviewed for possible switch or discontinuation (only in patients who are not psychotic and can be safely tapered) especially if TD is detected early; 23,24 unfortunately, early signs of TD are often missed, and it may become irreversible once established.”
Historical perspectives on tardive dyskinesia
Caroff, S. N., Ungvari, G. S., & Cunningham Owens, D. G. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.015 · Cited by 55 · see citing works
Long-Acting Oral vs Injectable Antipsychotic Drugs in Schizophrenics
Quitkin, F. M. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310095007 · Cited by 55 · see citing works
Tardive Dyskinesia: Reversible and Irreversible
Casey, D. E. (1985) · Psychopharmacology series · doi:10.1007/978-3-642-70140-5_11 · Cited by 54 · see citing works
The effects of electroconvulsive therapy on tardive dyskinesia
Tr, P., & Levin, R. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.8.991 · Cited by 53 · see citing works
L-DOPA reversal of hyperdopaminergic behaviour
Ezrin‐Waters, C., & Seeman, P. M. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90271-0 · Cited by 50 · see citing works
Bergman, H., Rathbone, J., Agarwal, V., & Soares‐Weiser, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000459.pub3 · Cited by 50 · see citing works
Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease
Brown, P., & Funk, S. C. (1986) · Journal of Health and Social Behavior · doi:10.2307/2136311 · Cited by 47 · see citing works
“throughout the course of TD (Quitkin et al. 1977).”
Bergman, H., Walker, D., Nikolakopoulou, A., Soares‐Weiser, K., & Adams, C. E. (2017) · Health Technology Assessment · doi:10.3310/hta21430 · Cited by 45 · see citing works
Emerging drugs in Tourette syndrome
Silay, Y. S., & Jankovic, J. J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.365 · Cited by 44 · see citing works
“In a series of 12 psychiatric patients, 24 – 62 years old, tardive dyskinesia developed after treatment for as short a period as 1 month to as long as 10 years [67].”
BackgroundCan the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?
Wolfarth, S., & Ossowska, K. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90036-5 · Cited by 44 · see citing works
Estevez‐Fraga, C., Zeun, P., & López-Sendón, J. L. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0590-y · Cited by 36 · see citing works
Overcoming barriers to effective management of tardive dyskinesia
Caroff, S. N. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s196541 · Cited by 34 · see citing works
“older reports found remission from TD a few months after drug cessation occurring in 50%–75% of patients if detected early.(45,46) While these early cases may represent reversible withdrawal dyskinesias, they nevertheless support the potential efficacy of drug withdrawal in nonpsychotic patients as a management option.”
BackgroundManagement of Tardive Syndrome: Medications and Surgical Treatments
Factor, S. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00898-3 · Cited by 34 · see citing works
Failure of lithium treatment in established tardive dyskinesia
Mackay, A. V. P., Sheppard, G. P., Saha, B. K., Motley, B., Johnson, A. L., & MARSDEN, C. D. (1980) · Psychological Medicine · doi:10.1017/s0033291700047498 · Cited by 33 · see citing works
“The situation could be different in recent-onset TD where a prophylactic action of Li might prevent further deterioration of dyskinesia in those patients requiring continued neuroleptic medication (Quitkin et al. 1977).”
BackgroundPeabody, C. A., Warner, M. D., Whiteford, H., & Hollister, L. E. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb02315.x · Cited by 33 · see citing works
Tardive dyskinesia and informed consent
Sovner, R., DiMascio, A., Berkowitz, D., & Randolph, P. (1978) · Psychosomatics · doi:10.1016/s0033-3182(78)71009-1 · Cited by 32 · see citing works
Recent Advances in the Pharmacology of Tardive Dyskinesia
Caroff, S. N. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.493 · Cited by 31 · see citing works
“ter drug withdrawal [54-56], older reports found remission of TD after drug cessation occurring in 50−75% of patients if detected early [57,58].”
BackgroundLarach, V. W., Zamboni, R., Mancini, H. R., Rueda, R. M., & Torres, R. G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00130-8 · Cited by 29 · see citing works
Relationship Between the B-Mitten EEG Pattern and Tardive Dyskinesia
Wegner, J. T. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050109016 · Cited by 28 · see citing works
Management of Tardive Dyskinesia
Simpson, G. M., Pi, E. H., & Sramek, J. J. (1982) · Drugs · doi:10.2165/00003495-198223050-00003 · Cited by 27 · see citing works
Follow-up study on the reversibility of tardive dyskinesia
Wegner, J. T., & Kane, J. M. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.368 · Cited by 27 · see citing works
The differential diagnosis of tardive dyskinesia
Casey, D. E. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb02460.x · Cited by 25 · see citing works
A 10‐year follow‐up study of tardive dyskinesia
YASSA, R., & Nair, N. P. V. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03264.x · Cited by 24 · see citing works
Tardive Dyskinesia and Problems of Assessment
Barnes, T. R. E., & Kidger, T. (1979) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-04494-8_12 · Cited by 24 · see citing works
Progress in the Treatment of Tardive Dyskinesia: Theory and Practice
Feltner, D. E., & Hertzman, M. (1993) · Psychiatric Services · doi:10.1176/ps.44.1.25 · Cited by 23 · see citing works
Early onset of tardive dyskinesia: case report
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.10.1323 · Cited by 20 · see citing works
Treatment of Tardive Dyskinesia
Lhoste, F., Lemaire, F., & RAPIN, M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704282961718 · Cited by 20 · see citing works
Antipsychotic-Induced Tardive Dyskinesia
Cavallaro, R., & Smeraldi, E. (1995) · CNS Drugs · doi:10.2165/00023210-199504040-00005 · Cited by 18 · see citing works
Psychopharmakotherapie affektiver Psychosen
Woggon, B. (1987) · Springer eBooks · doi:10.1007/978-3-642-71819-9_10 · Cited by 18 · see citing works
Friedman, J. H. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000754 · Cited by 17 · see citing works
Yagi, G., & Itoh, H. (1985) · The Keio Journal of Medicine · doi:10.2302/kjm.34.211 · Cited by 17 · see citing works
Tardive Dyskinesia: Management and New Treatment
Casey, D. E., & Gerlach, J. (1984) · Springer eBooks · doi:10.1007/978-94-011-7618-7_12 · Cited by 17 · see citing works
A new era in the diagnosis and treatment of tardive dyskinesia
Caroff, S. (2022) · CNS Spectrums · doi:10.1017/s1092852922000992 · Cited by 11 · see citing works
Follow-up study of 11 patients with potentially reversible tardive dyskinesia
Yagi, G., & Itoh, H. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1496 · Cited by 16 · see citing works
Choline chloride in animal models of tardive dyskinesia
Davis, K. L., Hollister, L. E., Vento, A. L., & Simonton, S. C. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90621-5 · Cited by 16 · see citing works
A single-blind study of ECT in patients with tardive dyskinesia
Asnis, G. M., & Leopold, M. A. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.10.1235 · Cited by 15 · see citing works
Tardive dyskinesia: Myths and Realities
Ananth, J. (1980) · Psychosomatics · doi:10.1016/s0033-3182(80)73668-x · Cited by 15 · see citing works
Effects of Neuroleptic Reduction in Schizophrenic Outpatients Receiving High Doses
Leblanc, G., Cormier, H. J., Gagné, M.-A., & Vaillancourt, S. (1994) · The Canadian Journal of Psychiatry · doi:10.1177/070674379403900406 · Cited by 15 · see citing works
“o :activation' (3-21); e : anxiety-depressiori" (4-28) ; .”
BackgroundSix month evaluation of thiopropazate hydrochloride in tardive dyskinesia.
Smith, J. S., & Kiloh, L. G. (1979) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.42.6.576 · Cited by 14 · see citing works
Tardive Dyskinesia and Other Drug-Induced Movement Disorders
FANN, W. E. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_21 · Cited by 14 · see citing works
Management of the Behavioral Symptoms Associated with Dementia
Eimer, M. (1989) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)01099-x · Cited by 13 · see citing works
Clinical controversies in tardive dyskinesia
Mackay, A. V. P. (1981) · Elsevier eBooks · doi:10.1016/b978-0-407-02295-9.50019-9 · Cited by 13 · see citing works
McGrath, J. J., & Soares-Weiser, K. (1998) · doi:10.1002/14651858.cd000459 · Cited by 13 · see citing works
Long-Term Drug Treatment of Psychosis: Observations on some Current Issues
Johnson, D. A. W. (1990) · International Review of Psychiatry · doi:10.3109/09540269009026605 · Cited by 10 · see citing works
Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics
Chouinard, G., & Steinberg, S. I. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80151-6 · Cited by 10 · see citing works
Prevention/treatment of tardive dyskinesia
Gerlach, J. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb02464.x · Cited by 10 · see citing works
“As TD is reversible in the beginning (Quitkin et al. (1977)) it is crucial to detect the syndrome as early as possible.”
BackgroundNeuroleptic-opiod interaction: Relevance to tardive dyskinesia
Sandyk, R. (1986) · International Journal of Neuroscience · doi:10.3109/00207458608985652 · Cited by 10 · see citing works
Tardive Syndromes in the Elderly
Chou, K. L., & Friedman, J. H. (2006) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.06.008 · Cited by 9 · see citing works
Tardive Dyskinesia in Psychogeriatric Patients: A Five‐Year Follow‐Up
Mehta, D., Mehta, S., & Mathew, P. (1977) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1977.tb00839.x · Cited by 9 · see citing works
Neuroleptic‐Induced Acute Extrapyramidal Syndromes and Tardive Dyskinesia
Mattay, V. S., & Casey, D. E. (2003) · doi:10.1002/9780470987353.ch28 · Cited by 9 · see citing works
Drug-Induced Tardive Dyskinesia
Itoh, H. (1981) · Springer eBooks · doi:10.1007/978-94-011-8123-5_4 · Cited by 8 · see citing works
Neurological Complications of Antipsychotic Drugs
Haddad, P. M., & Mattay, V. S. (2010) · doi:10.1002/9781444327298.ch27 · Cited by 8 · see citing works
Gelenberg, A. J. (1983) · Springer eBooks · doi:10.1007/978-1-4615-8049-2_4 · Cited by 8 · see citing works
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00019-6 · Cited by 7 · see citing works
Prevention of Tardive Dyskinesia
Pi, E. H., & Simpson, G. M. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5038-5_9 · Cited by 7 · see citing works
Gelenberg, A. J. (1991) · Springer eBooks · doi:10.1007/978-1-4757-1137-0_4 · Cited by 6 · see citing works
Chouinard, G., & Steinberg, S. I. (1984) · Springer eBooks · doi:10.1007/978-94-011-7618-7_13 · Cited by 6 · see citing works
Reversibility of Tardive Dyskinesia
Itoh, H., & Yagi, G. (1979) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1979.tb00173.x · Cited by 6 · see citing works
Tardive dyskinesia after low-dose haloperidol
Peabody, C. A., Brody, D. S., & Warner, M. D. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90138-7 · Cited by 5 · see citing works
Struve, F. A., Kane, J. M., Wegner, J. T., & Kantor, J. S. (1979) · Clinical Electroencephalography · doi:10.1177/155005947901000304 · Cited by 5 · see citing works
The life expectancy of schizophrenic patients with tardive dyskinesia
Inada, T., Koshiishi, M., Ohnishi, K., & Yagi, G. (1992) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470070404 · Cited by 5 · see citing works
Movement Disorders and Neuroleptic Medication
Barnes, T. R. E., & Weller, M. P. I. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5038-5_18 · Cited by 5 · see citing works
Muller, P., & Seeman, P. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_10 · Cited by 5 · see citing works
YASSA, R. (1985) · The Canadian Journal of Psychiatry · doi:10.1177/070674378503000614 · Cited by 4 · see citing works
“This was also noted by Quitkin et al (16) who observed that first symptoms of TD rarely persisted if antipsychotics were discontinued and concluded that the length of time symptoms have persisted prior to drug discontinuation may be the major variable determining reversibility of the syndrome.”
A Drug-free Month for Outpatient Schizophrenics
Carpenter, W. T. (1978) · Schizophrenia Bulletin · doi:10.1093/schbul/4.2.148 · Cited by 4 · see citing works
“…detected early, may be a re- by guest on N ovem ber 8, 2016 http://schizophreniabulletin.oxfordjournals.org/ D ow nloaded from VOL. 4, NO. 2, 1978 149 versible neurologic syndrome if medication is not continued (Crane 1975, Jacobson and Baldessarini 1975, Jus et al. 1976,.and Quitkin et al. 1977).”
BackgroundA Summary of Current Information, Mechanisms and Treatment
Inoue, F. (1979) · Annals of Pharmacotherapy · doi:10.1177/106002807901300402 · Cited by 4 · see citing works
A Classification of the Neurologic Effects of Neuroleptic Drugs
Crane, G. E. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_18 · Cited by 4 · see citing works
Tardive neuroleptic-induced dyskinesias
Захаров, Д. В., Buriak, I. V., & Mihailov, V. A. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212201131 · Cited by 3 · see citing works
Rabbit syndrome: patchy disapperance in stage 1 nrem sleep.
Gangadhar, B. N., John, C., Chattergi, S., Keshavan, M. S., & Narayanan, H. S. (1981) · PubMed Central · Cited by 3 · see citing works
Struve, F. A., Ramsey, P. P., Kane, J. M., & Willner, A. E. (1982) · Springer eBooks · doi:10.1007/978-94-009-7654-2_56 · Cited by 3 · see citing works
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50023-1 · Cited by 2 · see citing works
Tardive Dyskinesia and Institutional Practice: Current Issues and Guidelines
Opler, L. A., Katz, I. R., Kobayashi, J. S., & Ruiz, P. (1980) · Psychiatric Services · doi:10.1176/ps.31.4.239 · Cited by 2 · see citing works
Tardive Dyskinesia: A Review of the Treatment Possibilities
Jeste, D. V., & Wyatt, R. J. (1980) · Psychiatric Annals · doi:10.3928/0048-5713-19800101-05 · Cited by 2 · see citing works
Tardive dyskinesia following low doses of piperacetazine
Dominguez, R. A. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.12.1617 · Cited by 2 · see citing works
Deanol Trials in Tardive Dyskinesia
Casey, D. E. (1979) · Springer eBooks · doi:10.1007/978-1-4613-2934-3_10 · Cited by 2 · see citing works
Lynn, S. A., & Plant, R. (1995) · Clinical Rehabilitation · doi:10.1177/026921559500900202 · Cited by 1 · see citing works
- Authors
- Quitkin, F. M., Rifkin, A. E., Gochfeld, L., & Klein, D. F.
- Venue
- American Journal of Psychiatry
- Published
- 1977-01-01
- Volume
- 134
- Issue
- 1
- Pages
- 84-87
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2414414545
- Cited by
- 114
- References
- 16
- Citations by year
- 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2014: 1
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- tardive dyskinesia, antipsychotic adverse effects, reversibility, antipsychotic discontinuation, symptom duration, age of onset, psychiatric patients
- MeSH terms
- Adult, Chlorpromazine, Dyskinesia, Drug-Induced, Female, Fluphenazine, Haloperidol, Humans, Male, Middle Aged, Prognosis, Remission, Spontaneous, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review